Matches in Nanopublications for { ?s ?p "[As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion description "[As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_provenance.
- NP1296146.RA03L6nERrPNgRJkuEgrHMzPDhuQZiz-slEvLDDKURIS4130_assertion description "[As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296146.RA03L6nERrPNgRJkuEgrHMzPDhuQZiz-slEvLDDKURIS4130_provenance.